Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
about
Recent Advances in Tumor Ablation for Hepatocellular CarcinomaLiver Diseases and Long Non-Coding RNAs: New Insight and PerspectiveThe new era of hepatitis C virus therapyThe impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list.Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease.Value of radiofrequency ablation in the treatment of hepatocellular carcinomaHepatitis C infection in Egypt: prevalence, impact and management strategies.Nutrition and exercise in the management of liver cirrhosisImage-guided percutaneous ablation of hepatic malignancies.The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.A systematic review and meta-analysis of traditional insect Chinese medicines combined chemotherapy for non-surgical hepatocellular carcinoma therapyTPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression.Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinomaExcess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trialHepatocellular carcinoma: From diagnosis to treatment.Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options.Treatment of patients with HCV related cirrhosis: many rewards with very few risks.Chronic hepatitis C in saudi arabia: three years local experience in a university hospital.Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C.Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.Economic and Public Health Impacts of Policies Restricting Access to Hepatitis C Treatment for Medicaid Patients.Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors.Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.Histone acetyl transferase GCN5 promotes human hepatocellular carcinoma progression by enhancing AIB1 expressionThe miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.The effect of alendronate on proteome of hepatocellular carcinoma cell lines.Risk factors for the development of depression in patients with hepatitis C taking interferon-α.Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions.Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.The impact of hepatitis C burden: an evidence-based approach.Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityTransarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses.GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.
P2860
Q26775418-9C911941-B281-41DE-BBC5-6A489F921CF5Q28084106-39892F91-2C1C-407B-98C1-5D7D59BC4312Q28086947-15A1E4F8-BC92-4FBB-9B53-CE9051B98DD6Q30250096-CA32AEA2-5106-4694-B7C0-62D6589BEDDFQ30620900-F95F91C7-3D0F-4834-AB7F-1443F7A5FED7Q31119452-92CCCCED-7613-43B3-A3DB-7297343BD8F3Q33405520-F9C44D8A-FB39-4F02-8ECB-08E970293770Q33423474-015034AF-4D51-4DBB-A106-6A2D9848BDB5Q33661046-CA2EEAE3-4D53-4574-BC6B-3369B95DAE35Q33713718-3606AA0E-B45A-4D61-88DC-C45B3E08B912Q33780141-0F069B36-D2D3-4D6C-8F1B-A017BC45BFCAQ33832472-8F211151-AEAA-4B01-9918-E731C89E324EQ33838601-A382CA10-577E-45C4-91B1-187D91F3D6F9Q33845513-2DA0DB48-EBE2-462F-A30B-88BEF28F4D25Q33849037-A490E225-00C1-4176-B24C-54389B977FA6Q34130156-3254F3AA-5264-4D23-9B7A-E7C19DD5C954Q34483623-592E3BFD-843B-492C-9041-BA40B00D7CC1Q34778315-FC6902D5-FEDA-4961-AC91-DFBB335FF774Q35131882-5BDABDF0-B4F5-4ACF-9030-B85B44D88FD8Q35322521-E05349BB-5230-4DA1-BA50-14B6F698DF37Q35668716-DF53ABA8-D00D-48A6-8BD0-21643CD6B482Q35900280-D2C6465A-13C3-4BEA-83C3-36A73CFF7112Q36142732-888DCD9F-6DB9-488A-8B49-D8781D278520Q36329009-A52695FB-2F87-4142-ADC8-CFB86548BF5FQ36479439-EF5169B5-0DC4-4AA1-A584-B0D3F529EF41Q36821936-6456CF8D-0999-436F-88A0-65EBA2054C08Q37027342-72D15647-284B-4D5E-83A8-2B4EBE180D63Q37031741-B470E929-63D4-45F6-9541-8CC68CB73351Q37098646-0D628DE0-9401-4F1D-BD5A-8C99C3141FA6Q37109693-85DAC001-A695-463F-8F50-F7EA3276A664Q37144686-E5344FE3-3139-4961-9BDE-81B3E1CB768FQ37363464-8B5EDD85-2285-4404-8D17-8F16C94F1F56Q37599483-614E9FD6-45CE-4844-8C1B-DD9C2C07A684Q37886673-D9E453AF-8D40-4E8B-A661-901634A4C9B9Q38095820-F5245D7C-178A-4530-A82B-1402F9F9380CQ38170197-6F5B5CDC-E8CF-4281-A225-7FE9956B4B75Q38181631-AEBE5B76-B080-4C03-8357-56F2C03A81B8Q38198618-5B77E294-9D34-41DC-822C-A62E950C48FCQ38206111-1047DEAA-83BD-4C73-B6DC-5C4AE7AC13CDQ38237281-2F3ECD1D-FD1C-4DC9-89E7-8BEAF5C54858
P2860
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
@en
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
@nl
type
label
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
@en
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
@nl
prefLabel
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
@en
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
@nl
P2093
P1476
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection
@en
P2093
P304
P356
10.1111/J.1365-2036.2010.04370.X
P407
P577
2010-05-22T00:00:00Z